Application of a high-throughput quantitative PCR system for simultaneous monitoring of SARS-CoV-2 variants and other pathogenic viruses in wastewaterArticle Published on 2022-12-202022-11-15 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] acute respiratory syndrome Alpha variant analyzed application applied assays can be used collected Community coronavirus coronavirus disease COVID-19 delta variant demonstrated detect eight epidemiologically FIVE Health High-throughput qPCR highlighting increase Japan L452R labor-intensive likelihood Mie N501Y nine nucleotide nucleotide substitution pathogenic virus pathogenic viruses Pathogenic viruses, SARS-CoV-2 Patient PCR positive prevalent qPCR quantitative PCR quarantine reported RNA RT-qPCR SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 variant separated Surveillance target tested time-consuming Treatment virus viruses Volume wastewater Wastewater. Yokkaichi [DOI] 10.1016/j.scitotenv.2022.158659 PMC 바로가기
Advances and applications of nanophotonic biosensors Reviews Published on 2022-01-192022-10-05 Journal: Nature nanotechnology [Category] 바이오마커, [키워드] added advance Biochemistry biological samples complex ENhance handling Health highlight IMPROVE interactions limitation Mie Numerous reducing review sensitivity Volume [DOI] 10.1038/s41565-021-01045-5 [Article Type] Reviews
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort studyObservational Study Published on 2021-12-172022-10-04 Journal: PLoS Medicine [Category] SARS, 임상, [키워드] 95% confidence interval adjusted age analysis calculate ChAdOx1 ChAdOx1 vaccine changed characterized CIs Combination Comorbidity confounder coronavirus 2 country covariate Coverage COVID-19 COVID-19 pandemic Cox regression model creating death Denmark distribution dose Effectiveness estimate events first dose follow-up time General population gram Heterologous heterologous vaccine Homologous vaccine Hospital admission Hospitalization Immunity individual individuals Infection knowledge limitation male median age Mie mRNA vaccine National outcomes Poisson population-based cohort previous study recommendation reduction in Registration registry data Research researcher respiratory risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine second dose Sex study period study population subsequent System vaccination Vaccine Vaccines was obtained were used [DOI] 10.1371/journal.pmed.1003874 PMC 바로가기 [Article Type] Observational Study